These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 23392591)
1. A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study. Hirata S; Dirven L; Shen Y; Centola M; Cavet G; Lems WF; Tanaka Y; Huizinga TW; Allaart CF Rheumatology (Oxford); 2013 Jul; 52(7):1202-7. PubMed ID: 23392591 [TBL] [Abstract][Full Text] [Related]
2. The multi-biomarker disease activity score tracks response to rituximab treatment in rheumatoid arthritis patients: a post hoc analysis of three cohort studies. Roodenrijs NMT; de Hair MJH; Wheater G; Elshahaly M; Tekstra J; Teng YKO; Lafeber FPJG; Hwang CC; Liu X; Sasso EH; van Laar JM Arthritis Res Ther; 2018 Nov; 20(1):256. PubMed ID: 30458871 [TBL] [Abstract][Full Text] [Related]
3. A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis. Ma MHY; Defranoux N; Li W; Sasso EH; Ibrahim F; Scott DL; Cope AP Arthritis Res Ther; 2020 Jun; 22(1):158. PubMed ID: 32580789 [TBL] [Abstract][Full Text] [Related]
4. Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis. Reiss WG; Devenport JN; Low JM; Wu G; Sasso EH Rheumatol Int; 2016 Feb; 36(2):295-300. PubMed ID: 26026604 [TBL] [Abstract][Full Text] [Related]
5. A multi-biomarker disease activity score tracks clinical response consistently in patients with rheumatoid arthritis treated with different anti-tumor necrosis factor therapies: A retrospective observational study. Hirata S; Li W; Defranoux N; Cavet G; Bolce R; Yamaoka K; Saito K; Tanaka Y Mod Rheumatol; 2015 May; 25(3):344-9. PubMed ID: 25295918 [TBL] [Abstract][Full Text] [Related]
6. An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression. van der Helm-van Mil AH; Knevel R; Cavet G; Huizinga TW; Haney DJ Rheumatology (Oxford); 2013 May; 52(5):839-46. PubMed ID: 23287359 [TBL] [Abstract][Full Text] [Related]
7. Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial. Brahe CH; Østergaard M; Johansen JS; Defranoux N; Wang X; Bolce R; Sasso EH; Ørnbjerg LM; Hørslev-Petersen K; Stengaard-Pedersen K; Junker P; Ellingsen T; Ahlquist P; Lindegaard H; Linauskas A; Schlemmer A; Dam MY; Hansen I; Lottenburger T; Ammitzbøll C; Jørgensen A; Krintel SB; Raun J; Hetland ML Scand J Rheumatol; 2019 Jan; 48(1):9-16. PubMed ID: 29985080 [TBL] [Abstract][Full Text] [Related]
8. Predictive ability, validity, and responsiveness of the multi-biomarker disease activity score in patients with rheumatoid arthritis initiating methotrexate. Luedders BA; Johnson TM; Sayles H; Thiele GM; Mikuls TR; O'Dell JR; England BR Semin Arthritis Rheum; 2020 Oct; 50(5):1058-1063. PubMed ID: 32911284 [TBL] [Abstract][Full Text] [Related]
9. Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity. Curtis JR; van der Helm-van Mil AH; Knevel R; Huizinga TW; Haney DJ; Shen Y; Ramanujan S; Cavet G; Centola M; Hesterberg LK; Chernoff D; Ford K; Shadick NA; Hamburger M; Fleischmann R; Keystone E; Weinblatt ME Arthritis Care Res (Hoboken); 2012 Dec; 64(12):1794-803. PubMed ID: 22736476 [TBL] [Abstract][Full Text] [Related]
10. Association of the multi-biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha inhibitor treatment in clinical practice. Hirata S; Li W; Kubo S; Fukuyo S; Mizuno Y; Hanami K; Sawamukai N; Yamaoka K; Saito K; Defranoux NA; Tanaka Y Mod Rheumatol; 2016 Nov; 26(6):850-856. PubMed ID: 26873570 [TBL] [Abstract][Full Text] [Related]
11. Development of a multi-biomarker disease activity test for rheumatoid arthritis. Centola M; Cavet G; Shen Y; Ramanujan S; Knowlton N; Swan KA; Turner M; Sutton C; Smith DR; Haney DJ; Chernoff D; Hesterberg LK; Carulli JP; Taylor PC; Shadick NA; Weinblatt ME; Curtis JR PLoS One; 2013; 8(4):e60635. PubMed ID: 23585841 [TBL] [Abstract][Full Text] [Related]
12. Correlation of the Multi-Biomarker Disease Activity Score With Rheumatoid Arthritis Disease Activity Measures: A Systematic Review and Meta-Analysis. Johnson TM; Register KA; Schmidt CM; O'Dell JR; Mikuls TR; Michaud K; England BR Arthritis Care Res (Hoboken); 2019 Nov; 71(11):1459-1472. PubMed ID: 30320973 [TBL] [Abstract][Full Text] [Related]
13. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Wells G; Becker JC; Teng J; Dougados M; Schiff M; Smolen J; Aletaha D; van Riel PL Ann Rheum Dis; 2009 Jun; 68(6):954-60. PubMed ID: 18490431 [TBL] [Abstract][Full Text] [Related]
14. Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial. Hambardzumyan K; Bolce R; Saevarsdottir S; Cruickshank SE; Sasso EH; Chernoff D; Forslind K; Petersson IF; Geborek P; van Vollenhoven RF Ann Rheum Dis; 2015 Jun; 74(6):1102-9. PubMed ID: 24812287 [TBL] [Abstract][Full Text] [Related]
15. Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study. Bakker MF; Cavet G; Jacobs JW; Bijlsma JW; Haney DJ; Shen Y; Hesterberg LK; Smith DR; Centola M; van Roon JA; Lafeber FP; Welsing PM Ann Rheum Dis; 2012 Oct; 71(10):1692-7. PubMed ID: 22596166 [TBL] [Abstract][Full Text] [Related]
16. A multibiomarker disease activity score for rheumatoid arthritis predicts radiographic joint damage in the BeSt study. Markusse IM; Dirven L; van den Broek M; Bijkerk C; Han KH; Ronday HK; Bolce R; Sasso EH; Kerstens PJ; Lems WF; Huizinga TW; Allaart CF J Rheumatol; 2014 Nov; 41(11):2114-9. PubMed ID: 25128518 [TBL] [Abstract][Full Text] [Related]
17. A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure. Hambardzumyan K; Saevarsdottir S; Forslind K; Petersson IF; Wallman JK; Ernestam S; Bolce RJ; van Vollenhoven RF Arthritis Rheumatol; 2017 May; 69(5):953-963. PubMed ID: 27992691 [TBL] [Abstract][Full Text] [Related]
18. Investigation of a multi-biomarker disease activity score in rheumatoid arthritis by comparison with magnetic resonance imaging, computed tomography, ultrasonography, and radiography parameters of inflammation and damage. Krabbe S; Bolce R; Brahe CH; Døhn UM; Ejbjerg BJ; Hetland ML; Sasso EH; Chernoff D; Hansen MS; Knudsen LS; Hansen A; Madsen OR; Hasselquist M; Møller J; Østergaard M Scand J Rheumatol; 2017 Sep; 46(5):353-358. PubMed ID: 27682742 [TBL] [Abstract][Full Text] [Related]
19. Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis. Kuriya B; Schieir O; Lin D; Xiong J; Pope J; Boire G; Haraoui B; Thorne JC; Tin D; Hitchon C; Jamal S; Keystone E; Bykerk VP; Clin Exp Rheumatol; 2017; 35(5):799-803. PubMed ID: 28339365 [TBL] [Abstract][Full Text] [Related]
20. Relationship of multi-biomarker disease activity score and other risk factors with radiographic progression in an observational study of patients with rheumatoid arthritis. Li W; Sasso EH; van der Helm-van Mil AH; Huizinga TW Rheumatology (Oxford); 2016 Feb; 55(2):357-66. PubMed ID: 26385370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]